POST FORUM SITE
ATTENDEES
SPEAKERS
PRESENTERS
​​​EXHIBITORS
INVESTORS
SPONSORS
SUPPORTERS
​​​SEEDS


​ABOUT 19th BEF

PARTICIPATING COMPANIES INCLUDED:

4D Lifetec AG 
4D Path, Inc.
AbbVie Ventures
AbbVie, Inc.
Ability Pharmaceuticals, SL
Abingworth LLP
Abionic S.A.
Accequa AB
Acesion Pharma ApS
ACXIT Capital Management GmbH
ACXIT Capital Managment GmbH
Addex Therapeutics Ltd.
Adocia
Advent France Biotechnology
Affimed N.V.
AGENDIA BV
Aglaia Oncology Funds
Aleph Bot Ltd.
Allena Pharmaceuticals
ALSA Holdings Ltd.
aMoon Fund
AmorChem Venture Fund
AMYRA Biotech AG
Anagenesis Biotechnologies SAS
Anaveon AG
Andera Partners
Anergis SA
Angelini ACRAF s.p.a.
Anima Biotech, Inc.
Apeiron Biologics AG
Aptose Biosciences, Inc.
Aravis SA
Arix Bioscience Plc.
Arthurian Life Sciences
Asklepios Advisors
Aston LS Capital
AstraZeneca BioVentureHub
Atelix Ltd.
ATGN Consulting
Atlantic Bone Screen
ATRIVA Therapeutics GmbH
Atturos Ltd.
Aurealis Pharma AG
Auriga Partners
Auris Medical AG
Ayoxxa Biosystems GmbH
B3C Group GmbH
Bachem AG
Back Bay HealthCare Capital
Barcode Diagnostics
BaselArea.swiss
BaseLaunch
Bay City Capital LLC
BB Pureos Bioventures
BeiGene GmbH
Bellevue
Bergmann zur Hausen & Cie. GmbH
Bio Medi Gene Ventures
BioElectron Technology Corporation
BioGeneration Ventures
BioMedInvest
BioMedPartners AG
BioPharma Advisory
Biophytis SA
Biopôle SA
Biosceptre (UK) Ltd.
BioSeed Capital
BioSense Global LLC
BIOSTART
Biotech Alliances International, Inc.
Biotrial Research SAS
BioVersys AG
BioXplor
Bird & Bird LLP
BLAC-BioPharma UG
Bloomberg
Bluetech, Investment Fund
Boehringer Ingelheim International GmbH
Bohe Angel Fund
Bootstrap Europe
Boston Pharmaceuticals, Inc.
Bpifrance
BRAINCURES
Breslin AG
Bristol-Myers Squibb
British Embassy Berne
Brothers & Partners Europe
Bryan, Garnier & Co
C-Bridge Capital
Caelus Health B.V.
Cantargia AB
Capital Grand Est
Capricorn Venture Partners
Caribou Biosciences, Inc.
Catalyze B.V.
Causaly, Inc.
CDR-Life AG
Cederberg GmbH
Cellestia Biotech AG
Ceretrieve Ltd.
CIS Pharma AG
Clinuvel Pharmaceuticals Ltd.
CNNMoney Switzerland
Colpman Consulting Ltd.
Complix NV
ConneKTia International
Corinthian Financial Management Ltd
CORPOGEN
Creathor Ventures
Crescendo Biologics Ltd.
Csendes Consulting
Cue Biopharma, Inc.
Cukierman & Co. Life Sciences
DDF Ventures B.V.
densys3D
DHBW Lörrach
Dicronis AG
Digital Networks PLC
docdok.health
Droia NV
Dyadic International, Inc.
E. Gutzwiller & Cie, Banquiers
Earlybird Health-Tech Management GmbH & Co. KG
Economic and Trade Department, Embassy of Israel
Edison Group
EIT Health e.V.
Ekins Guinness LLP
Eli Lilly and Company
Elthera AG
Emerald Health Sciences, Inc.
Epidarex
Ernst & Young AG
Esperante Ventures
Euronext
European Investment Bank
EUSA Pharma, Inc.
EVA - the Basel life sciences start-up agency
Everads Therapy
Evotec International
Exogenus Therapeutics S.A.
F-star Biotechnology Ltd.
F. Hoffmann-La Roche Ltd.
Fondation Eclosion
Forendo Pharma Ltd.
Fosun Group
Fraser Finance
FreeMind Group
GamaMabs Pharma SA
GeNeuro SA
GenSearch Switzerland
Gilde Healthcare
Gimv
GL Capital Group
GlaxoSmithKline
goetzpartners Corporate Finance GmbH
GoingPublic Media AG
Grabulovski Consulting Services
GSK
Guggenheim Securities
Gyntools
H.C. Wainwright & Co.
H.C. Wainwright & Co., LLC
Hadean Ventures
HalioDx
Hangzhou Chen Miao Yuan Biotechnology Co., Ltd.
HBM Partners AG
Health Passion Fund
HealthCap
HealthCare Royalty Partners
Herantis Pharma Plc.
High-Tech Gruenderfonds Management GmbH
Hoffmann & Co AG
HT BioImaging
ICF Consult (Switz.)
IGEM Therapeutics Ltd.
Illumina Ventures
ILTOO Pharma
Image Analysis Group
IMI Consulting GmbH
Immune System Key (ISK) Ltd.
Immunicum AB

Immunomic Therapeutics, Inc.
Indelve
​Inkef Capital BV
Innogest
INOFEA AG
Inositec AG
Inotrem S.A.
Instinctif Partners
InterAx Biotech AG
Inthera Bioscience AG
Inveready Asset Management
investiere Verve Capital Partners
Investor Verlag
IOCB TECH s. r. o.
iOnctura SA
IP Group Plc
IPF Partners
ISA Pharmaceuticals B.V.
Israeli Embassy in Bern, Switzerland
Jina Ventures, Inc.
Johnson & Johnson
JPIF
Karyopharm Therapeutics, Inc.
Keapstone Therapeutics Ltd.
Kronos Advisors
LSFA
LSP
LSWorks LLC
Lundbeckfond Emerge
M Ventures
Maruho Co., Ltd.
MaxPro Ventures
Medherant Limited
Medical Valley Ventures
Medicxi Ventures
MedVenture GmbH
Memo Therapeutics AG
Menarini Ricerche S.p.A.
Merck KGaA
Merck KGaA / EMD Serono
metaLinear Ltd.
Metys Pharmaceuticals AG
MGC Pharma Pty.
MISSION Therapeutics Ltd.
Modra Pharmaceuticals B.V.
Momentum Biotech
Monitus Research
MotionTech
MP Healthcare Venture Management
MRL Ventures Fund
Mundipharma Research Ltd.
Mymetics SA
Nanobiotix Corp.
Neem Biotech Ltd.
NETRIS Pharma
Neurimmune AG
New Science Fund
Nextech Invest Ltd.
Norgine Ventures
Novago Therapeutics S.A.
Novaremed AG
Novartis Pharma AG
Novartis Venture Fund
Novian Health, Inc.
Novo Holdings A/S
Novo Nordisk A/S
Novo Ventures
NxR Biotechnologies GmbH
Oberland Capital
Omega Funds
OncoVita
OrbiMed
Oryzon Genomics S.A.
OSE Immunotherapeutics
Otsuka Pharmaceutical
Parkinson's UK
Paulson Investment Company
PBimmunomics
PDC*line Pharma SA
Pfizer, Inc.
Phanes Therapeutics, Inc.
Pharmaleads SA
PharmaVentures Ltd.
Pharmstandard Ventures
Philimmune, LLC
Plas-free
PM Equity Partner
PMV
Polyneuron Pharmaceuticals AG
Positive Capital
PRC Biomedical
Premier Research
Prescient Healthcare Group
Primer Capital
Privateq Advisors AG
PROPONENT Biotech GmbH
ProteoDesign
Qnami
Quan Capital
Quotient Sciences Ltd.
RBC Capital Markets
RBV Capital
Reactive Robotics GmbH
Recordati S.p.A.
Redalpine Venture Partners
Rejuvenate Biomed NV
ReNeuron Group PLC
Roche Partnering
Roche Venture Fund
Salus Partners SA
Schroder Adveq
Schwarz Financial Communication
Scipio bioscience
scPharmaceuticles
Sebana
Selvita S.A.
Senes Science
Sensorion SA
Seroba Life Sciences
Seventure Partners
Silicon Valley Bank
Sofimac Innovation
Staatz BD & Strategy
Staatz Business Development & Strategy
Stalicla SA
Startupticker.ch
Stifel
Strategic Swiss Partners
Strekin AG
Suenos Advisors Est.
SUN bioscience
SunRegen Healthcare AG
Sunstone Capital A/S
SysBioSim B.V.
Takeda Pharmaceuticals International AG
Takeda Ventures, Inc.
Talix Therapeutics
TapImmune Inc.
TargImmune Therapeutics AG
Teva Pharmaceuticals
The Cell-Factory
The Coulter Partnership Ltd.
The Fulford Group Ltd.
The German Accelerator Life Sciences (GALS)
Themis Bioscience GmbH
ThromboGenics NV
TiCure
TikoMed
TOLREMO Therapeutics AG
Topas Therapeutics GmbH
Torreya Partners, LLP
Trendlines Medical
Turos Capital AG
TVM Capital China Limited
TVM Capital Life Science
UCB Ventures
UGISense AG
University of Turin
University of Zurich
V-Bio Ventures
Valor Management SA
valuationLAB AG
Vaximm AG
Ventac Partners
Venture Valuation AG
Versameb AG
Versant Venture
Versantis AG
VI Partners AG
Vida Ventures
Virdis Group
VisionHealth GmbH
Vogel BioC
Voyager MR
Wellington Partners
Wilson Sonsini Goodrich & Rosati
Xeraya Capital
YA Global, LP
Ysios Capital Partners
Zambon S.p.A.
ZygoFix

* More to be announced. Last updated on 19.09.2018